Intervention effect of simvastatin on vasculopathy in diabetic rats and its mechanism
Wang Min-zhe
Abstract
Wang Min-zhe
Abstract
Objective:To observe the effects of simvastatin on intercellular adhesion molecule-1(ICAM-1) levels in diabetic macroangiopathy rats and to find its possible protective effects on macroangiopathy.Methods:Duplicating rat model of diabetes complicating macroangiopathy,rats were randomly assigned to normal controlgroup(group A),normal intervention group(group B),diabetic control group(group C) and diabetic intervention group(group D).Simvastatin was given to the group B and D by gavage,while the group A and B were gavaged with corresponding normal saline.At the end of 8 weeks,the biochemical indexes,perirenal fat and serum ICAM-1 were detected and the thoracic aorta was taken for observing the pathological change.Results:The blood glucose levels in group C and D was similar,which was significantly higher than that in the group A and B(P0.01);total cholesterol,triglyceride and low density lipoprotein in group A were much higher than those in the group B,the group D was lower than the group C;ICAM-1 in the group C was much higher than that in the group A,B and D(P0.01),the group D was much lower than the group C(P0.01);the pathological changes of aorta thoracalis by light microscope showed that the group D was milder than the group C.Conclusion:Simvastatin intervention treatment can decrease TC,TG,LDL-C and ICAM-1 level and obviously alleviate or delay the occurrence and development of macroangiopathy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the effects of simvastatin on intercellular adhesion molecule-1(ICAM-1) levels in diabetic macroangiopathy rats and to find its possible protective effects on macroangiopathy.Methods:Duplicating rat model of diabetes complicating macroangiopathy,rats were randomly assigned to normal controlgroup(group A),normal intervention group(group B),diabetic control group(group C) and diabetic intervention group(group D).Simvastatin was given to the group B and D by gavage,while the group A and B were gavaged with corresponding normal saline.At the end of 8 weeks,the biochemical indexes,perirenal fat and serum ICAM-1 were detected and the thoracic aorta was taken for observing the pathological change.Results:The blood glucose levels in group C and D was similar,which was significantly higher than that in the group A and B(P0.01);total cholesterol,triglyceride and low density lipoprotein in group A were much higher than those in the group B,the group D was lower than the group C;ICAM-1 in the group C was much higher than that in the group A,B and D(P0.01),the group D was much lower than the group C(P0.01);the pathological changes of aorta thoracalis by light microscope showed that the group D was milder than the group C.Conclusion:Simvastatin intervention treatment can decrease TC,TG,LDL-C and ICAM-1 level and obviously alleviate or delay the occurrence and development of macroangiopathy.
Key concepts: Simvastatin, Medicine, Group B, Internal medicine, Triglyceride, Group A, Aorta, Diabetes mellitus